FIELD: chemistry.
SUBSTANCE: claimed is application of potassium salt 2-[1-(1,1-dioxothietanyl-3)benz-imidazolyl-2-thio]acetic acid (known as immunomodulator) as medication, possessing anxiolytic action. It is demonstrated that action of claimed medication on different anxiety components is comparable with effect of standard anxiolytics phenazepam and afobazole, but it is not accompanied by myorelaxant action characteristic of benzodiasepin anxiolytics (phenazepam).
EFFECT: improvement of composition efficiency.
2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT POSSESSING ANXIOLYTHIC ACTION, ON BASIS OF HYDROGENATED PYRIDO (4,3-b) INDOLES (VERSIONS), PHARMACOLOGICAL AGENT ON ITS BASIS AND WAY OF ITS APPLICATION | 2007 |
|
RU2338533C1 |
| AGENT POSSESSING ANXIOLYTIC ACTIVITY | 2015 |
|
RU2571286C1 |
| METHOD OF TREATMENT OF NEUROSIS-LIKE AND MARGINAL DISORDERS | 1993 |
|
RU2102986C1 |
| USE OF PEPTIDE Gly-His-Lus-Gly-Pro TO ACHIEVE ANXIOLYTIC EFFECT | 2019 |
|
RU2705592C1 |
| QUINAZOLINE DERIVATIVES, POSSESSING ANTIDEPRESSANT, ANXIOLYTIC AND NOOTROPIC ACTIVITY | 2012 |
|
RU2507199C1 |
| 2-ETHYL-6-METHYL-3-OXYPYRODINE SALTS WITH ORGANIC CARBOXYLIC ACIDS POSSESSING ANXIOLYTIC, ANTIDEPRESSIVE, ANTIHYPOXIC, ANTI-AMNESTIC AND ANTI-OXIDATIVE ACTIVITY AND METHOD FOR THEIR PREPARING | 2002 |
|
RU2284993C2 |
| MEDICATION POSSESSING ANXIOLYTIC ACTION | 2008 |
|
RU2394588C1 |
| PHENYLHYDRAZIDE (4-PHENYL-2-PYRROLIDON-1-YL)-ACETIC ACID, HAVING NOOTROPIC, ANTIDEPRESSANT AND ANXIOLYTIC ACTIVITY | 2010 |
|
RU2440981C1 |
| PROLONGED ACTION PHARMACEUTICAL COMPOSITION BASED ON 5-ETHOXY-2-[2-(MORPHOLINO)-ETHYLTHIO]BENZIMIDAZOLE DIHYDROCHLORIDE AND/OR BASE (APHOBAZOLUM) | 2017 |
|
RU2694837C2 |
| ANTIDEPRESSANT, ANXIOLYTIC, NEUROPROTECTIVE AND IMMUNOSTIMULATING AGENT | 2010 |
|
RU2429834C1 |
